Your A-Z of episodes

Did you know there’s even more we can do to promote your episode? Find out more…

  • Episode 245

    The CEO leading Ensera’s evolution

    Jason Anderson

    / Ensera

    Jason Anderson, CEO of Ensera (formerly SteriPack) discusses about the pharmaceutical and biotechnology supply chain.

  • Episode 244

    CPHI 2025 wrap-up

    Raman Sehgal

    / Molecule to Market Host

    Our host Raman Sehgal discusses the themes and vibe of CPHI 2025 in Frankfurt.

  • Episode 243

    20 years of CPHI – Veterans Guide

    Veterans

    /

    Raman gathers great insider tips from a wise group of veterans of CPHI who have two decades of experience.

  • Episode 242

    Themes from PBOA Conference 2025

    Gil Roth

    / Pharma & Biopharma Outsourcing Association (PBOA)

    Gil Roth, President, at Pharma & Biopharma Outsourcing Association (PBOA) discusses the themes from this year’s PBOA Conference.

  • Episode 241

    The understated CDMO CCO

    Jean-Baptiste

    / Agnus

    JB Agnus, CCO of Bora Pharmaceuticals joins our podcast discussing about the pharmaceutical and biotechnology supply chain.

  • Episode 240

    The CEO driving change at Curia

    Philip Macnabb

    / Curia

    Philip Macnabb, CEO of Curia joins podcast to discuss his private equity experience and navigating the COVID comedown at Curia.

  • Episode 239

    The People-first CEO of FUJIFILM Biotechnologies

    Lars Petersen

    / FUJIFILM Biotechnologies

    Lars Petersen, President & Chief Executive Officer at FUJIFILM Biotechnologies joins the podcast to discuss his transition to the CDMO side.

  • Episode 238

    Driving growth and removing waste for big pharma

    Matt Lowe

    / Performance.io/

    Matt Lowe, Founder and CEO of Performance.io/ discusses seeing a niche in SEO within the healthcare space.

  • Episode 237

    Riding the ups and downs of entrepreneurship

    Michael Scholl

    / Leukocare

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Michael Scholl, Chief Executive Officer and Co-Founder at Leukocare. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Michael, covering: Michael Scholl is the Co-founder and Chief Executive Officer of Leukocare, a

  • Episode 236

    Unlocking CDMO growth via commercial excellence

    Kaan-Fabian Kekec

    / Simon-Kucher

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Kaan-Fabian Kekec, Partner in Healthcare and Life Sciences at Simon-Kucher. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Kaan, covering: Kaan leads the firm’s Healthcare B2B and Pharma Services business globally,

  • Load more